Hypertension -- Table of Contents (50 [5])

About This Cover

Volume 50, Issue 5; November 1, 2007

Hypertension Grand Rounds
Hypertension Case Report
Editorial Commentaries
Original Articles
Letters to the Editor
Corrections

To see an article, click its "Full Text" or "PDF" link. To review many abstracts, check the boxes to the left of the titles you want, and click the "Get All Checked Abstract(s)" button. To see one abstract at a time, click its "Abstract" link.

button_lock_image article is free immediately upon publication

	Hypertension Grand Rounds
	Management of Uncontrollable Hypertension With a Carotid Sinus Stimulation Device Markus G. Mohaupt, Jürg Schmidli, and Friedrich C. Luft Hypertension. 2007;50:825-828; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.099416 Full Text \| PDF
	Hypertension Case Report
	Autoimmune Hypertensive Syndrome David C. Kem, Xichun Yu, Eugene Patterson, Shijun Huang, Stavros Stavrakis, Bela Szabo, Leann Olansky, Jon McCauley, and Madeleine W. Cunningham Hypertension. 2007;50:829-834; published online before print October 8 2007, doi:10.1161/HYPERTENSIONAHA.107.096750 Full Text \| PDF
	Editorial Commentaries
	Qualitative Assessment of Sympathetic Neural Drive in Cardiometabolic Disease: A New Challenge Guido Grassi Hypertension. 2007;50:835-836; published online before print October 1 2007, doi:10.1161/HYPERTENSIONAHA.107.096974 Full Text \| PDF
	Will the Lessons From Primary Aldosteronism Change the Treatment of Hypertension and Left Ventricular Hypertrophy? Richard J. Auchus and Mark H. Drazner Hypertension. 2007;50:837-839; published online before print October 1 2007, doi:10.1161/HYPERTENSIONAHA.107.097303 Full Text \| PDF
	Mineralocorticoid Receptor Activation and Oxidative Stress John W. Funder Hypertension. 2007;50:840-841; published online before print October 8 2007, doi:10.1161/HYPERTENSIONAHA.107.098012 Full Text \| PDF
	Avoiding Vicious Circles: Mineralocorticoid Receptor Antagonism Prevents Vascular Oxidative Stress Early After Myocardial Infarction Ralf P. Brandes Hypertension. 2007;50:842-843; published online before print September 17 2007, doi:10.1161/HYPERTENSIONAHA.107.098699 Full Text \| PDF
	Is Peroxisome Proliferator-Activated Receptor- ${gamma}$ a New "Pal" of Renin? Eric T. Weatherford, Hana Itani, Henry L. Keen, and Curt D. Sigmund Hypertension. 2007;50:844-846; published online before print September 4 2007, doi:10.1161/HYPERTENSIONAHA.107.097519 Full Text \| PDF
	Peroxisome Proliferator-Activated Receptor– ${alpha}$ : Friend or Foe? Chana Yagil and Yoram Yagil Hypertension. 2007;50:847-850; published online before print October 1 2007, doi:10.1161/HYPERTENSIONAHA.107.100461 Full Text \| PDF
	Left Ventricular Hypertrophy Reversal and Prevention of Diabetes: Two Birds With One Stone? Giuseppe Schillaci, Matteo Pirro, and Elmo Mannarino Hypertension. 2007;50:851-853; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.099747 Full Text \| PDF
	Original Articles
	Blood Pressure Control in Hispanics in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Karen L. Margolis, Linda B. Piller, Charles E. Ford, Mario A. Henriquez, William C. Cushman, Paula T. Einhorn, Pedro J. Colon, Sr, Donald G. Vidt, Rudell Christian, Nathan D. Wong, Jackson T. Wright, Jr, David C. Goff, Jr for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group Hypertension. 2007;50:854-861; published online before print September 10 2007, doi:10.1161/HYPERTENSIONAHA.107.092650 Abstract \| Full Text \| PDF
	Differing Pattern of Sympathoexcitation in Normal-Weight and Obesity-Related Hypertension Elisabeth Lambert, Nora Straznicky, Markus Schlaich, Murray Esler, Tye Dawood, Elodie Hotchkin, and Gavin Lambert Hypertension. 2007;50:862-868; published online before print October 1 2007, doi:10.1161/HYPERTENSIONAHA.107.094649 Abstract \| Full Text \| PDF
	Antecedent Blood Pressure, Body Mass Index, and the Risk of Incident Heart Failure in Later Life Douglas S. Lee, Joseph M. Massaro, Thomas J. Wang, William B. Kannel, Emelia J. Benjamin, Satish Kenchaiah, Daniel Levy, Ralph B. D’Agostino, Sr, and Ramachandran S. Vasan Hypertension. 2007;50:869-876; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.095380 Abstract \| Full Text \| PDF
	Salt-Induced Nephropathy in Obese Spontaneously Hypertensive Rats Via Paradoxical Activation of the Mineralocorticoid Receptor: Role of Oxidative Stress Miki Nagase, Hiromitsu Matsui, Shigeru Shibata, Takanari Gotoda, and Toshiro Fujita Hypertension. 2007;50:877-883; published online before print September 17 2007, doi:10.1161/HYPERTENSIONAHA.107.091058 Abstract \| Full Text \| PDF \| Data Supplement
	Sex and Body Mass Index Specific Regulation of Blood Pressure by CYP19A1 Gene Variants Reposo Ramirez-Lorca, Antonio Grilo, Maria Teresa Martinez-Larrad, Luis Manzano, Francisco Javier Serrano-Hernando, Francisco Jesus Moron, Vicente Perez-Gonzalez, Jose Luis Gonzalez-Sanchez, Javier Fresneda, Rosario Fernandez-Parrilla, Guillermo Moñux, Eva Molero, Elena Sanchez, Maria Jose Martinez-Calatrava, Jose Saban-Ruiz, Agustin Ruiz, Maria Eugenia Saez, and Manuel Serrano-Rios Hypertension. 2007;50:884-890; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.096263 Abstract \| Full Text \| PDF \| Data Supplement
	Congenic Interval Mapping of RNO10 Reveals a Complex Cluster of Closely-Linked Genetic Determinants of Blood Pressure Yasser Saad, Shane Yerga-Woolwine, Jagannath Saikumar, Phyllis Farms, Ezhilarasi Manickavasagam, Edward J. Toland, and Bina Joe Hypertension. 2007;50:891-898; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.097105 Abstract \| Full Text \| PDF \| Data Supplement
	Yohimbine Attenuates Baroreflex-Mediated Bradycardia in Humans Jens Tank, Karsten Heusser, André Diedrich, Robert J. Brychta, Friedrich C. Luft, and Jens Jordan Hypertension. 2007;50:899-903; published online before print September 17 2007, doi:10.1161/HYPERTENSIONAHA.107.095984 Abstract \| Full Text \| PDF
	Chronic Baroreceptor Activation Enhances Survival in Dogs With Pacing-Induced Heart Failure Irving H. Zucker, Johnnie F. Hackley, Kurtis G. Cornish, Bradley A. Hiser, Nicholas R. Anderson, Robert Kieval, Eric D. Irwin, David J. Serdar, Jacob D. Peuler, and Martin A. Rossing Hypertension. 2007;50:904-910; published online before print September 10 2007, doi:10.1161/HYPERTENSIONAHA.107.095216 Abstract \| Full Text \| PDF \| Data Supplement
	Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism Cristiana Catena, GianLuca Colussi, Roberta Lapenna, Elisa Nadalini, Alessandra Chiuch, Pasquale Gianfagna, and Leonardo A. Sechi Hypertension. 2007;50:911-918; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.095448 Abstract \| Full Text \| PDF \| CME
	Mineralocorticoid Receptor Blockade Improves Vasomotor Dysfunction and Vascular Oxidative Stress Early After Myocardial Infarction Carmem Luíza Sartório, Daniela Fraccarollo, Paolo Galuppo, Meike Leutke, Georg Ertl, Ivanita Stefanon, and Johann Bauersachs Hypertension. 2007;50:919-925; published online before print September 10 2007, doi:10.1161/HYPERTENSIONAHA.107.093450 Abstract \| Full Text \| PDF
	Novel Regulatory Effect of Angiotensin II Type 1 Receptor-Interacting Molecule on Vascular Smooth Muscle Cells Koichi Azuma, Kouichi Tamura, Atsu-ichiro Shigenaga, Hiromichi Wakui, Shin-ichiro Masuda, Yuko Tsurumi-Ikeya, Yutaka Tanaka, Masashi Sakai, Miyuki Matsuda, Tatsuo Hashimoto, Tomoaki Ishigami, Marco Lopez-Ilasaca, and Satoshi Umemura Hypertension. 2007;50:926-932; published online before print September 17 2007, doi:10.1161/HYPERTENSIONAHA.107.096115 Abstract \| Full Text \| PDF \| Data Supplement
	Renin Enhancer Is Crucial for Full Response in Renin Expression to an In Vivo Stimulus M. Andrea Markus, Christine Goy, David J. Adams, Frank J. Lovicu, and Brian J. Morris Hypertension. 2007;50:933-938; published online before print September 10 2007, doi:10.1161/HYPERTENSIONAHA.107.096891 Abstract \| Full Text \| PDF
	Peroxisome Proliferator-Activated Receptor- ${gamma}$ Is Involved in the Control of Renin Gene Expression Vladimir T. Todorov, Michael Desch, Nina Schmitt-Nilson, Anelia Todorova, and Armin Kurtz Hypertension. 2007;50:939-944; published online before print September 4 2007, doi:10.1161/HYPERTENSIONAHA.107.092817 Abstract \| Full Text \| PDF \| Data Supplement
	Absence of Peroxisome Proliferator-Activated Receptor- ${alpha}$ Abolishes Hypertension and Attenuates Atherosclerosis in the Tsukuba Hypertensive Mouse Karen M. Tordjman, Clay F. Semenkovich, Trey Coleman, Rachel Yudovich, Stella Bak, Etty Osher, Michal Vechoropoulos, and Naftali Stern Hypertension. 2007;50:945-951; published online before print October 1 2007, doi:10.1161/HYPERTENSIONAHA.107.094268 Abstract \| Full Text \| PDF \| Data Supplement
	Angiotensin II Induces Capillary Formation From Endothelial Cells Via the LOX-1–Dependent Redox-Sensitive Pathway Changping Hu, Abhijit Dandapat, and Jawahar L Mehta Hypertension. 2007;50:952-957; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.096446 Abstract \| Full Text \| PDF
	Extracellular Renal Guanosine Cyclic 3'5'-Monophosphate Modulates Nitric Oxide– and Pressure-Induced Natriuresis Farah Ahmed, Brandon A. Kemp, Nancy L. Howell, Helmy M. Siragy, and Robert M. Carey Hypertension. 2007;50:958-963; published online before print September 10 2007, doi:10.1161/HYPERTENSIONAHA.107.092973 Abstract \| Full Text \| PDF
	Fourier Analysis of the Envelope of the Ophthalmic Artery Blood Flow Velocity: Age- and Blood Pressure–Related Impact Georg Michelson, Joanna Harazny, Roland E. Schmieder, Rainer Berendes, Thomas Fiermann, and Simone Wärntges Hypertension. 2007;50:964-969; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.095463 Abstract \| Full Text \| PDF \| Data Supplement
	Endothelial Function and Chronic Exposure to Air Pollution in Normal Male Subjects Marie Briet, Cédric Collin, Stéphane Laurent, Alice Tan, Michel Azizi, Mohsen Agharazii, Xavier Jeunemaitre, François Alhenc-Gelas, and Pierre Boutouyrie Hypertension. 2007;50:970-976; published online before print September 17 2007, doi:10.1161/HYPERTENSIONAHA.107.095844 Abstract \| Full Text \| PDF \| Data Supplement
	Association of Increased Plasma Cardiotrophin-1 With Inappropriate Left Ventricular Mass in Essential Hypertension Begoña López, José M. Castellano, Arantxa González, Joaquín Barba, and Javier Díez Hypertension. 2007;50:977-983; published online before print September 10 2007, doi:10.1161/HYPERTENSIONAHA.107.098111 Abstract \| Full Text \| PDF
	In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Peter M. Okin, Richard B. Devereux, Katherine E. Harris, Sverker Jern, Sverre E. Kjeldsen, Lars H. Lindholm, Björn Dahlöf for the LIFE Study Investigators Hypertension. 2007;50:984-990; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.096818 Abstract \| Full Text \| PDF
	Letters to the Editor
	Aldosterone Rapidly Induces Leukocyte Adhesion to Endothelial Cells: A New Link Between Aldosterone and Arteriosclerosis? Alexander W. Krug, Steffi Kopprasch, Christian G. Ziegler, Sandra Dippong, Rusan A. Catar, Stefan R. Bornstein, Henning Morawietz, and Michael Gekle Hypertension. 2007;50:e156-e157; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.099531 Full Text \| PDF
	Increased Blood Pressure Variability in Aging Rats After Intrauterine Growth Restriction Michiel F. Schreuder, Joanna A.E. van Wijk, and Henriette A. Delemarre-van de Waal Hypertension. 2007;50:e158; published online before print September 17 2007, doi:10.1161/HYPERTENSIONAHA.107.099994 Full Text \| PDF
	Acarbose and Postprandial Hypotension Diana Gentilcore, Michael Horowitz, and Karen L. Jones Hypertension. 2007;50:e159; published online before print September 10 2007, doi:10.1161/HYPERTENSIONAHA.107.097717 Full Text \| PDF
	Response to Acarbose and Postprandial Hypotension Cyndya Shibao and Italo Biaggioni Hypertension. 2007;50:e160; published online before print September 10 2007, doi:10.1161/HYPERTENSIONAHA.107.097931 Full Text \| PDF
	Brachial Pulse Pressure and Cardiovascular Risk Jacques Blacher, Michel E. Safar, Claire Vesin, and Annie Rudnichi Hypertension. 2007;50:e161; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.097808 Full Text \| PDF
	Response to Brachial Pulse Pressure and Cardiovascular Risk William J. Mosley, II, Philip Greenland, Daniel B. Garside, and Donald M. Lloyd-Jones Hypertension. 2007;50:e162; published online before print October 1 2007, doi:10.1161/HYPERTENSIONAHA.107.097949 Full Text \| PDF
	Do Commercially Available Assay Kits for B-Type Natriuretic Peptide Measure Pro-BNP1-108, as Well as BNP1-32? Toshio Nishikimi, Naoto Minamino, Kazukiyo Horii, and Hiroaki Matsuoka Hypertension. 2007;50:e163; published online before print September 17 2007, doi:10.1161/HYPERTENSIONAHA.107.098350 Full Text \| PDF
	Response to Do Commercially Available Assay Kits for B-Type Natriuretic Peptide Measure Pro-BNP1-108, as Well as BNP1-32? Denise Heublein, Brenda Huntley, Guido Boerrigter, Alessandro Cataliotti, Sharon Sandberg, Margaret Redfield, and John C. Burnett, Jr Hypertension. 2007;50:e164; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.098384 Full Text \| PDF
	Unexpected Therapeutic Response to Spironolactone: A Prospective Debate on Aldosterone and Potassium Ion in Hypertension Antonio Delgado-Almeida Hypertension. 2007;50:e165-e164; published online before print September 10 2007, doi:10.1161/HYPERTENSIONAHA.107.099408 Full Text \| PDF
	Response to Unexpected Therapeutic Response to Spironolactone: A Prospective Debate on Aldosterone and Potassium Ion in Hypertension Theodore L. Goodfriend Hypertension. 2007;50:e166-e164; published online before print September 17 2007, doi:10.1161/HYPERTENSIONAHA.107.099671 Full Text \| PDF
	Preeclamptic Superoxide-Anion Production: Is There an Increase or a Failure of Reduction? Rudolf Lampé, Sándor Szucs, Róza Ádány, and Robert Póka Hypertension. 2007;50:e167-e164; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.100107 Full Text \| PDF
	Response to Preeclamptic Superoxide-Anion Production: Is There an Increase or a Failure of Reduction? Kiyomi Tsukimori, Hitoo Nakano, and Norio Wake Hypertension. 2007;50:e168-e164; published online before print September 24 2007, doi:10.1161/HYPERTENSIONAHA.107.100412 Full Text \| PDF
	Corrections
	Corrections Hypertension. 2007;50:e169; published online before print October 1 2007, doi:10.1161/HYPERTENSIONAHA.107.009591 Full Text \| PDF
	Corrections Hypertension. 2007;50:e170; published online before print October 1 2007, doi:10.1161/HYPERTENSIONAHA.107.009592 Full Text \| PDF

Spotlight

TOC Spotlight File

Volume 50, Issue 5; November 1, 2007

Hypertension Grand Rounds

Management of Uncontrollable Hypertension With a Carotid Sinus Stimulation Device

Hypertension Case Report

Autoimmune Hypertensive Syndrome

Editorial Commentaries

Qualitative Assessment of Sympathetic Neural Drive in Cardiometabolic Disease: A New Challenge

Will the Lessons From Primary Aldosteronism Change the Treatment of Hypertension and Left Ventricular Hypertrophy?

Mineralocorticoid Receptor Activation and Oxidative Stress

Avoiding Vicious Circles: Mineralocorticoid Receptor Antagonism Prevents Vascular Oxidative Stress Early After Myocardial Infarction

Is Peroxisome Proliferator-Activated Receptor- a New "Pal" of Renin?

Peroxisome Proliferator-Activated Receptor–: Friend or Foe?

Left Ventricular Hypertrophy Reversal and Prevention of Diabetes: Two Birds With One Stone?

Original Articles

Blood Pressure Control in Hispanics in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Differing Pattern of Sympathoexcitation in Normal-Weight and Obesity-Related Hypertension

Antecedent Blood Pressure, Body Mass Index, and the Risk of Incident Heart Failure in Later Life

Salt-Induced Nephropathy in Obese Spontaneously Hypertensive Rats Via Paradoxical Activation of the Mineralocorticoid Receptor: Role of Oxidative Stress

Sex and Body Mass Index Specific Regulation of Blood Pressure by CYP19A1 Gene Variants

Congenic Interval Mapping of RNO10 Reveals a Complex Cluster of Closely-Linked Genetic Determinants of Blood Pressure

Yohimbine Attenuates Baroreflex-Mediated Bradycardia in Humans

Chronic Baroreceptor Activation Enhances Survival in Dogs With Pacing-Induced Heart Failure

Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism

Mineralocorticoid Receptor Blockade Improves Vasomotor Dysfunction and Vascular Oxidative Stress Early After Myocardial Infarction

Novel Regulatory Effect of Angiotensin II Type 1 Receptor-Interacting Molecule on Vascular Smooth Muscle Cells

Renin Enhancer Is Crucial for Full Response in Renin Expression to an In Vivo Stimulus

Peroxisome Proliferator-Activated Receptor- Is Involved in the Control of Renin Gene Expression

Absence of Peroxisome Proliferator-Activated Receptor- Abolishes Hypertension and Attenuates Atherosclerosis in the Tsukuba Hypertensive Mouse

Angiotensin II Induces Capillary Formation From Endothelial Cells Via the LOX-1–Dependent Redox-Sensitive Pathway

Extracellular Renal Guanosine Cyclic 3'5'-Monophosphate Modulates Nitric Oxide– and Pressure-Induced Natriuresis

Fourier Analysis of the Envelope of the Ophthalmic Artery Blood Flow Velocity: Age- and Blood Pressure–Related Impact

Endothelial Function and Chronic Exposure to Air Pollution in Normal Male Subjects

Association of Increased Plasma Cardiotrophin-1 With Inappropriate Left Ventricular Mass in Essential Hypertension

In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study

Letters to the Editor

Aldosterone Rapidly Induces Leukocyte Adhesion to Endothelial Cells: A New Link Between Aldosterone and Arteriosclerosis?

Increased Blood Pressure Variability in Aging Rats After Intrauterine Growth Restriction

Acarbose and Postprandial Hypotension

Response to Acarbose and Postprandial Hypotension

Brachial Pulse Pressure and Cardiovascular Risk

Response to Brachial Pulse Pressure and Cardiovascular Risk

Do Commercially Available Assay Kits for B-Type Natriuretic Peptide Measure Pro-BNP1-108, as Well as BNP1-32?

Response to Do Commercially Available Assay Kits for B-Type Natriuretic Peptide Measure Pro-BNP1-108, as Well as BNP1-32?

Unexpected Therapeutic Response to Spironolactone: A Prospective Debate on Aldosterone and Potassium Ion in Hypertension

Response to Unexpected Therapeutic Response to Spironolactone: A Prospective Debate on Aldosterone and Potassium Ion in Hypertension

Preeclamptic Superoxide-Anion Production: Is There an Increase or a Failure of Reduction?

Response to Preeclamptic Superoxide-Anion Production: Is There an Increase or a Failure of Reduction?

Corrections

Corrections

Corrections

Spotlight

Is Peroxisome Proliferator-Activated Receptor- ${gamma}$ a New "Pal" of Renin?

Peroxisome Proliferator-Activated Receptor– ${alpha}$ : Friend or Foe?

Peroxisome Proliferator-Activated Receptor- ${gamma}$ Is Involved in the Control of Renin Gene Expression

Absence of Peroxisome Proliferator-Activated Receptor- ${alpha}$ Abolishes Hypertension and Attenuates Atherosclerosis in the Tsukuba Hypertensive Mouse